{
    "organizations": [],
    "uuid": "7b24f20d82887437b78e4592e211a8c0913be560",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abcam-says-entered-into-license-ag/brief-abcam-says-entered-into-license-agreement-with-roche-idUSL8N1PH1LX",
    "ord_in_thread": 0,
    "title": "BRIEF-Abcam Says Entered Into License Agreement With Roche​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Abcam Plc:\n* ‍HAS ENTERED INTO A DEFINITIVE LICENSE AGREEMENT WITH ROCHE​\n* ‍WILL OBTAIN EXCLUSIVE RIGHTS TO PRODUCT PORTFOLIO OF SPRING BIOSCIENCE CORPORATION IN RESEARCH USE ONLY (RUO) FIELD OF USE\n* ROCHE TO RETAIN ANTIBODY DEVELOPMENT CAPABILITIES, RIGHTS TO SPRING PORTFOLIO FOR INTERNAL RESEARCH, COMPANION DIAGNOSTIC, IVD USES​​\n* ALL PRODUCTS TO BE SOLD UNDER ABCAM BRAND, INCLUSIVE OF SP BRANDING, ARE EXPECTED TO BE AVAILABLE THROUGH ABCAM.COM FROM 21 FEBRUARY 2018​\n* GRANTED EXCLUSIVE RUO RIGHTS FOR FUTURE PRODUCTS DEVELOPED BY SPRING THAT ROCHE REQUESTS TO BE COMMERCIALISED IN RUO FIELD OF USE FOR INITIAL PERIOD OF 10 YEARS\n* ‍FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)\n ",
    "published": "2018-01-22T16:45:00.000+02:00",
    "crawled": "2018-01-23T17:51:17.031+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "abcam",
        "plc",
        "entered",
        "definitive",
        "license",
        "agreement",
        "obtain",
        "exclusive",
        "right",
        "product",
        "portfolio",
        "spring",
        "bioscience",
        "corporation",
        "research",
        "use",
        "ruo",
        "field",
        "use",
        "roche",
        "retain",
        "antibody",
        "development",
        "capability",
        "right",
        "spring",
        "portfolio",
        "internal",
        "research",
        "companion",
        "diagnostic",
        "ivd",
        "product",
        "sold",
        "abcam",
        "brand",
        "inclusive",
        "sp",
        "branding",
        "expected",
        "available",
        "february",
        "granted",
        "exclusive",
        "ruo",
        "right",
        "future",
        "product",
        "developed",
        "spring",
        "roche",
        "request",
        "commercialised",
        "ruo",
        "field",
        "use",
        "initial",
        "period",
        "year",
        "term",
        "agreement",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}